(Reuters) - The U.S. Food and Drug Administration on Thursday announced the first coronavirus-related drug shortage in the United States but declined to name the drug in question.
The regulator said a drugmaker had informed it of the shortage of one of its drugs because manufacturing of one of its main pharmaceutical ingredients was affected by the fast-moving virus outbreak.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!